| Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317) |
|---|
| 02/13/2002 | EP1179010A2 Previns as specific inhibitors and therapeutic agents for botulinum toxin b and tetanus neurotoxins |
| 02/13/2002 | EP1179008A2 Tetrapeptide revealing geroprotective effect, pharmacological substance on its basis, and the method of its application |
| 02/13/2002 | EP1178993A1 Thiazoloderiatives and pharmaceutical compositions containing them |
| 02/13/2002 | EP1178986A2 Furanone derivatives as inhibitors of cathepsin s |
| 02/13/2002 | EP1178984A2 1-trifluoromethyl-4-hydroxy-7-piperidinyl-aminomethylchroman derivatives |
| 02/13/2002 | EP1178983A1 Indole-type derivatives as inhibitors of p38 kinase |
| 02/13/2002 | EP1178981A1 Substituted 3-pyridyl-4-arylpyrroles, and related therapeutic and prophylactic methods |
| 02/13/2002 | EP1178973A2 Novel compounds, their use and preparation |
| 02/13/2002 | EP1178971A1 Substituted polycyclic aryl and heteroaryl uracils as anticoagulative agents |
| 02/13/2002 | EP1178970A1 Substituted polycyclic aryl and heteroaryl pyrymidinones useful as anticoagulants |
| 02/13/2002 | EP1178967A1 Quinoline derivatives as inhibitors of mek enzymes |
| 02/13/2002 | EP1178966A1 Quinoline derivatives as inhibitors of mek enzymes |
| 02/13/2002 | EP1178965A1 Quinoline derivatives as inhibitors of mek enzymes |
| 02/13/2002 | EP1178964A1 Substituted polycyclic aryl and heteroaryl pyridones useful for selective inhibition of the coagulation cascade |
| 02/13/2002 | EP1178963A1 Ion channel modulating agents |
| 02/13/2002 | EP1178960A1 Vitamin d analogues and their pharmaceutical use |
| 02/13/2002 | EP1178959A1 Alpha-amino-beta-sulfonyl hydroxamic acid compounds |
| 02/13/2002 | EP1178958A2 N-cyanomethyl amides as protease inhibitors |
| 02/13/2002 | EP1178954A1 A structure-based approach to design inhibitors of protein-processivity factor interactions |
| 02/13/2002 | EP1178834A1 Controlled release of growth factors from heparin containing matrices |
| 02/13/2002 | EP1178832A1 Novel medicament compositions, based on anticholinergically effective compounds and beta-mimetics |
| 02/13/2002 | EP1178831A1 Combined method of treatment comprising an aromatase inhibitor and a further biologically active compound |
| 02/13/2002 | EP1178819A2 Glutathione reductase for therapy and prophylaxis of aids |
| 02/13/2002 | EP1178817A2 Molecular interactions in haematopoietic cells |
| 02/13/2002 | EP1178810A2 Use of bisphosphonic acids for treating angiogenesis |
| 02/13/2002 | EP1178809A1 Pharmaceutical composition in unit form containing acetylsalcylic acid and clopidogrel hydrogenosulphate |
| 02/13/2002 | EP1178803A2 Opioid antagonists containing compositions for enhancing analgesic potency of tramadol and attenuating its adverse side effects |
| 02/13/2002 | EP1178802A1 Cyclic amidines useful as nmda nr2b antagonists |
| 02/13/2002 | EP1178800A1 Methods for treating neurodegenerative disorders using aspartyl protease inhibitors |
| 02/13/2002 | EP1178797A1 Inhibitors of impdh enzyme |
| 02/13/2002 | EP1178795A1 Dfmo and celecoxib in combination for cancer chemoprevention and therapy |
| 02/13/2002 | EP1178791A2 The use of a protein tyrosine kinase pathway inhibitor in the treatment of ocular disorders |
| 02/13/2002 | EP1178781A1 Multilayer pharmaceutical product for release in the colon |
| 02/13/2002 | EP1049695B1 2-phenyl substituted imidazotriazinones as phosphodiesterase inhibitors |
| 02/13/2002 | EP1042320B1 New compounds which are p2-purinoceptor 7-transmembrane (tm) g-protein coupled receptor antagonists |
| 02/13/2002 | EP1019726B1 Prevention of sudden infant death |
| 02/13/2002 | EP0946561B1 Triazolo(4,5-d)pyrimidinyl derivatives and their use as medicaments |
| 02/13/2002 | EP0861236B1 Cyclic and heterocyclic n-substituted alpha-iminohydroxamic and carboxylic acids |
| 02/13/2002 | EP0737199B1 Method for preparing concentrated biologically active silicon compounds |
| 02/13/2002 | EP0724600B1 Process for preparing an inter-alpha-trypsine inhibitor concentrate for therapeutical use, and concentrate thus obtained |
| 02/13/2002 | EP0693925B1 Production of a recombinant factor xa inhibitor of leech hirudo medicinalis |
| 02/13/2002 | CN1335887A Angiocidin: A Cys-Ser-Val-Thr-Cys-Gly specific tumor cell adhesion receptor |
| 02/13/2002 | CN1335881A UME extract having medicinal effects and compositions containing the same |
| 02/13/2002 | CN1335853A Alpha v beta b integrin inhibitors |
| 02/13/2002 | CN1335850A Quinoline derivatives |
| 02/13/2002 | CN1335849A Pyrrolopyrimidines as protein kinase inhibitors |
| 02/13/2002 | CN1335847A Sulfonamide compounds and uses thereof as medicines |
| 02/13/2002 | CN1335845A 3,4-dihydro-2H-benzo[1,4] oxazinyl-methyl [3-(1H-indol-3-yl)-alkyl]-amines |
| 02/13/2002 | CN1335841A N-(iminomethyl) amine derivatives, their preparation, their use as medicines and compositions containing them |
| 02/13/2002 | CN1335837A Imidazole compounds and medicinal use thereof |
| 02/13/2002 | CN1335836A Tricyclic pyrazole derivatives |
| 02/13/2002 | CN1335835A Arylpiperidine and aryl-1,2,5,6-tetrahydropyridine urea derivatives having 5HT1A receptor activity |
| 02/13/2002 | CN1335775A Bioflavonoids, anthocyanins and phenolic compounds from cherries for inhibiting inflammation and cyclooxygenase enzymes |
| 02/13/2002 | CN1335768A Multiparticulate modified release composition |
| 02/13/2002 | CN1335749A Method and compositions for treatment of cell proliferative disorders |
| 02/13/2002 | CN1335316A New N-triazolyl methyl piperazine derivate using as neurokinin receptor antagonistic agent |
| 02/13/2002 | CN1335163A Chinese medicine for treating cold and cough |
| 02/13/2002 | CN1335161A Deer bone powder capsule |
| 02/12/2002 | US6346626 Drugs for treatment of skin disorders such as acne, seborrhea, androgenic alopecia and hirsutism, or in the topical treatment of squamous cell carcinoma |
| 02/12/2002 | US6346624 Process for making 5-lipoxygenase inhibitors having varied heterocyclic ring systems |
| 02/12/2002 | US6346622 Enantiomorphs and isomers |
| 02/12/2002 | US6346611 High affinity TGfβ nucleic acid ligands and inhibitors |
| 02/12/2002 | US6346607 A protein that induces apoptosis or binds cytochrome c; diagnosis and therapy for multiple sclerosis, parkinson's and alzheimer's diseases, cardiovascular diseases, strokes, toxin induced liver disease, cancer, lupus and herpes virus |
| 02/12/2002 | US6346602 Peptide mimics of the cytokine receptor common γ chain and methods and compositions for making and using the same |
| 02/12/2002 | US6346550 Hydroxylation activated prodrugs |
| 02/12/2002 | US6346541 Antitumor and anticarcinogenic agents for breast, lung, and skin cancer |
| 02/12/2002 | US6346540 1-(1,2-disubstituted pipeidinyl)-4-substituted piperidine derivatives |
| 02/12/2002 | US6346539 Treatment of skin conditions |
| 02/12/2002 | US6346531 G-CSF mimetics |
| 02/12/2002 | US6346520 Antitumor and anticarcinogenic agents; psoriasis |
| 02/12/2002 | US6346391 Treating infection by administering drug to which the microorganism is resistant and an inhibitor of an acrab-like efflux pump |
| 02/12/2002 | US6346275 Drugs for immunology residues of corallinaceae, seaweed derivatives |
| 02/12/2002 | US6346246 Antibodies that bind human haemopoietic maturation factor |
| 02/12/2002 | CA2259152C Adenovirus e4 proteins for inducing cell death |
| 02/12/2002 | CA2094702C Substituted tetrahydropyridines and hydroxypiperidines as central nervous system agents |
| 02/12/2002 | CA2088742C Benzimidazole and imidazopyridine derivatives and their application |
| 02/12/2002 | CA2067877C Polycyclic amine compounds and their enantiomers, their method of preparation and pharmaceutical compositions in which they are present |
| 02/07/2002 | WO2002010766A2 Assay method, peptides and reagent kits for testing mrp-specific inhibitors |
| 02/07/2002 | WO2002010743A1 Improved anti-viral and anti-tumor chemotherapy by administration of erythropoeitin |
| 02/07/2002 | WO2002010426A1 Koji molds and use thereof for preparing cholesterol-lowering products |
| 02/07/2002 | WO2002010406A2 Metalloproteinase-disintegrin polypeptides and methods of making and use thereof |
| 02/07/2002 | WO2002010405A2 A human disintegrin protein |
| 02/07/2002 | WO2002010403A2 Regulation of human phosphatidylinositol-specific phospholipase c-like enzyme |
| 02/07/2002 | WO2002010388A2 C3b/C4b COMPLEMENT RECEPTOR-LIKE MOLECULES AND USES THEREOF |
| 02/07/2002 | WO2002010387A2 G-protein coupled receptors |
| 02/07/2002 | WO2002010379A2 Modified cea and uses thereof |
| 02/07/2002 | WO2002010369A1 Tumor antigen |
| 02/07/2002 | WO2002010363A2 Protein phosphatases |
| 02/07/2002 | WO2002010357A2 Gsk3 polypeptides |
| 02/07/2002 | WO2002010216A2 Proteins and nucleic acids encoding same |
| 02/07/2002 | WO2002010214A2 Growth differentiation factor receptors, agonists and antagonists thereof, and methods of using same |
| 02/07/2002 | WO2002010199A2 C3b/c4b complement receptor-like molecules and uses thereof |
| 02/07/2002 | WO2002010188A1 16alpha-methyl or ethyl substituted estrogens |
| 02/07/2002 | WO2002010171A1 Crystalline therapeutic agent |
| 02/07/2002 | WO2002010168A1 Novel guanidino derivatives as inhibitors of cell adhesion |
| 02/07/2002 | WO2002010166A1 Fused heterocyclic derivatives as phosphodiesterase inhibitors |
| 02/07/2002 | WO2002010165A1 Use of polycyclic aromatic compounds for making medicines capable of inhibiting telomerase |
| 02/07/2002 | WO2002010162A1 N-[5-[[[5-alkyl-2-oxazolyl]methyl]thio]-2-thiazolyl] carboxamide inhibitors of cyclin dependent kinases |
| 02/07/2002 | WO2002010159A1 Lactam inhibitors of factor xa which are useful for the treatment of thrombosis |
| 02/07/2002 | WO2002010158A2 3-indolyl-4-phenyl-1h-pyrrole-2,5-dione derivatives as inhibitors of glycogen synthase kinase-3beta |